Lucid Diagnostics (LUCD) Return on Capital Employed (2021 - 2026)
Lucid Diagnostics' (LUCD) quarterly Return on Capital Employed came in at 625.43% in Q1 2026, down 161728.0% YoY from N/an in Q1 2025, and down 129.8% on a QoQ basis from 272.16% in Q4 2025.
Lucid Diagnostics (LUCD) Return on Capital Employed (2021 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 6 years of Return on Capital Employed data on file, last reported at 625.43% in Q1 2026.
- Quarterly Return on Capital Employed fell 161728.0% year-over-year to 625.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 625.43% (down 161728.0% YoY) and the FY2025 annual result came in at 709.35%, up 13279.0% from the prior year.
- Return on Capital Employed fell to 625.43% in Q1 2026, from 272.16% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 991.86% in Q1 2025 to a low of 5540.8% in Q4 2023.
- A 5-year average of 636.21% and a median of 288.94% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 533260 bps — and 2024, when it soared 407063 bps.
- Tracing LUCD's Return on Capital Employed over 5 years: stood at 208.2% in 2022, then slumped by 2561 bps to 5540.8% in 2023, then jumped by 73 bps to 1470.17% in 2024, then soared by 81 bps to 272.16% in 2025, then tumbled by 130 bps to 625.43% in 2026.
- The last three Return on Capital Employed figures came in at 625.43% (Q1 2026), 272.16% (Q4 2025), and 243.33% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | Lucid Diagnostics | 176.13 Mn | 142.73 Mn | 55,000.00 | -563.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -563.35% |
| Mar 31, 2026 | -625.43% |
| Dec 31, 2025 | -272.16% |
| Sep 30, 2025 | -243.33% |
| Jun 30, 2025 | -760.17% |
| Mar 31, 2025 | 991.86% |
| Dec 31, 2024 | -1,470.17% |
| Sep 30, 2024 | -319.93% |
| Jun 30, 2024 | -260.61% |
| Mar 31, 2024 | -464.34% |
| Dec 31, 2023 | -5,540.80% |
| Sep 30, 2023 | -680.59% |
| Jun 30, 2023 | -288.94% |
| Mar 31, 2023 | -334.58% |
| Dec 31, 2022 | -208.20% |
| Sep 30, 2022 | -163.15% |
| Jun 30, 2022 | -97.38% |
| Mar 31, 2022 | -77.64% |
| Dec 31, 2021 | -101.98% |